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ABSTRACT 
 Global lack of mesencephalic astrocyte-derived neurotropic factor (MANF) leads to progressive 
postnatal loss of β-cells mass and insulin-dependent diabetes in mice. Similarly to Manf
-/-
 mice, 
embryonic ablation of MANF specifically from the pancreas results in diabetes. In this study, we 
assessed the importance of MANF for the postnatal expansion of the pancreatic β-cell mass and for 




 mice revealed mosaic 
MANF expression in postnatal pancreases and significant correlation between the number of 
MANF-positive β-cells and β-cell mass in individual mice. In vitro, recombinant MANF induced β-
cell proliferation in islets from aged mice and protected from hyperglycemia-induced endoplasmic 





 mice resulted in reduced β-cell mass and diabetes caused largely by β-cell ER 
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stress and apoptosis, possibly accompanied by β-cell de-differentiation and reduced rates of β-cell 
proliferation. Thus, MANF expression in adult mouse β-cells is needed for their maintenance in 
vivo. We also revealed a mechanistic link between ER stress, and inflammatory signaling pathways 
leading to β-cell death in the absence of MANF. Hence, MANF might be a potential target for 
regenerative therapy in diabetes. 
INTRODUCTION 
Insulin deficiency caused by autoimmune destruction of β-cells leads to type 1 diabetes (T1D) and 
β-cell death is also involved in the failure of insulin secretion that leads to type 2 diabetes (T2D) 
(1,2). Current diabetes therapies are based on treating hyperglycaemia, but they are not targeting 
basic disease mechanisms. As the prevalence of diabetes is rapidly increasing worldwide, it is 
important to develop new therapies to protect and restore the functional β-cell mass (3). 
Increasing evidence suggests that ER stress followed by prolonged activation of the UPR is one of 
the pathogenic mechanisms leading to β-cell death in both T1D and T2D (4-6).  Pancreatic β-cells 
are especially vulnerable to ER stress-mediated cell death due to their heavy demand of insulin 
production, depending of proper folding and secretion (7). ER stress is triggered by the 
accumulation of unfolded and misfolded proteins in the ER lumen leading to activation of UPR 
signalling cascades, which are mediated by three ER transmembrane protein sensors - PKR-like ER 
kinase (PERK), activating transcription factor 6 (ATF6) and inositol-requiring enzyme 1 (IRE1) (8). 
Mutations inactivating the PERK gene leads to ER dysfunction, neonatal diabetes and growth 
defects in patients with Wolcott-Rallison syndrome (WRS) (9).  Similarly, a homozygous mutation 
in the Perk gene leads to retarded growth and neonatal diabetes in mouse (10,11). In addition, 
inactivating mutations in several UPR genes result in β-cell death and diabetes in mice (12,13).  
MANF was originally described as a secreted trophic factor for dopamine neurons in vitro with 
protective roles for neurons and cardiomyocytes in rodent disease models (14-17). The protective 
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effect of MANF has been suggested to depend on its ability to dampen ER stress (15,16,18,19). The 
mechanisms whereby MANF acts and enters cells are not fully understood. It was suggested to bind 
with its C-terminal KDEL-motif (RTDL) to a KDEL-receptor at the cell surface and thereby enter 
the cell (20). Recently, MANF was shown to bind to lipid sulfatides on the cell surface followed by 
endocytosis (21). We recently discovered that MANF-deficiency in mice (Manf
-/-
 mice) led to 
postnatal reduction of the pancreatic β-cell mass and severe insulin-deficient diabetes due to 
decreased β-cell proliferation and increased β-cell death (22). ER stress and chronic activation of 
the UPR in β-cells was found to precede the loss of β-cells in Manf
-/-
 mice (22). Importantly, adeno-
associated virus (AAV) vector mediated overexpression of MANF was able to regenerate β-cells in 
vivo and recombinant MANF was able to increase proliferation rates of β-cells in vitro, indicating 
that MANF protein is a potential new drug candidate for the treatment of T1D (22).  
In the present study we examined the importance of MANF in vivo in mice by conditional removal 
of MANF specifically from pancreas and β-cells in embryo. Our results show that MANF 
expression in β-cells positively correlates with β-cell mass and negatively with β-cell apoptosis, 
further revealing the importance of MANF expression for β-cell survival. We further revealed the 





mice. This led to the development of diabetes caused by sustained ER stress 
resulting in increased β-cell death. Finally, we showed that MANF protein increased proliferation 
rates of even aged and MANF-deficient mouse β-cells in vitro. Thus, our work demonstrates that 
MANF is essential for the maintenance of adult β-cells in mice. 
 
RESEARCH DESIGN AND METHODS 
Animals and in vivo physiology 
All experimental procedures involving mice were approved by the Finnish Animal Ethics 
Committee. All mice were kept on a 12 hour dark/light cycle with free access to chow diet and 
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mice has been described previously (22) 
and Supplementary text). To delete MANF embryonically from the pancreas we used a Pdx-
1Cre
TUV
 transgenic mouse line (Jackson Laboratories, Stock 014647, C57BL/6J background) (23) 
crossed to Manf
fl/fl 
mice (Hsd:ICR(CD-1) background). To specifically remove MANF from the β-
cells in adult mice we used tamoxifen (TMX)-inducible MIP1-CreERT
1Lphi
 mice (24) (C57BL/6J 
background) crossed to Manf
fl/fl







 mice were injected with either 33 mg/kg of Tmx or corn oil for 5 
consecutive days. Four weeks post injection mice were sacrificed, tissues and sera analysed. All 
experimental animals were in mixed background. Analysis of blood samples were performed as 
described previously and in Supplementary Data. 
Histological Analysis  
Immunohistochemistry, quantification of β-cell mass, analysis of β-cell death were performed as 
described previously (22). For immunohistochemistry mouse pancreatic paraffin sections were 
stained with primary antibodies (Supplementary Table 1). For immunofluorescence staining 
appropriate secondary antibodies conjugated with Alexa Fluor® 488 or 568 (1:400, Molecular 
Probes, Life Technologies, Eugene, Oregon, USA) and DAPI (Vectorshield, Vector laboratories, 
Burlingame, USA) were used to visualize the labels. 
In Vitro β-cell Proliferation  
In vitro β-cell proliferation experiments were performed as previously described  and assessed by 
Click-iT™ EdU Alexa Fluor™647 Imaging Kit   (C10340, Invitrogen
TM
, Thermofisher Scientific, 
Waltham MA, USA) (22). Isolated islets form 1.3 year old or 4-5 week old Manf
-/-
 female mice 
were stimulated with recombinant human placental lactogen (500 ng/ml; Affiland) or recombinant 
human MANF (100 ng/ml; Icosagen) for 5 consecutive days in RPMI1640 media containing 11mM 
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glucose supplemented with 10% Fetal Bovine Serum (FBS) and antibiotics. Edu (10nM) was added 
to the culture medium for last 3 days of stimulation.  
To study cell signalling pathways, islets from Manf
-/-
 and control Manf
+/+
 mice were kept overnight 
in RPMI1640 supplemented with 10% FBS. Next day islets were starved in 0.5% bovine serum 
albumin (BSA) in RPMI medium for 3 hour and stimulated with 100 ng/ml rhMANF for 1 hour 
followed by islets homogenisation in 1x Laemmli buffer and western blotting analysis.   
Serial block-face scanning electron microscopy (SB-EM)  
Mice were perfused with 4% formaldehyde followed by cutting of pancreases in pieces. The pieces 
were post-fixed, stained and embedded based on a previously published protocol (25). The collected 
images were processed, aligned and analyzed using Microscopy Image Browser (26). 
Additional Materials and Methods 
The methods for western blotting, RNA analysis and methods concerning treatment of murine 
islets, serial block-face scanning electron microscopy analysis and subcellular localization analysis 
are provided in the Supplementary Data. 
Statistical Analysis 
All data are presented as mean ± SEM. Statistical significance was assessed via Student t-test 
between 2 groups or one-way ANOVA followed by the Tukey’s test between 4 groups as 
mentioned in the figure texts using GraphPad Prism 6 software (GraphPad Software, Inc., La 
Jolla,CA).  
RESULTS 
MANF is specifically expressed in β-cells in the islets of Langerhans   
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MANF is widely expressed in mouse tissues throughout the embryonic development and in 
adulthood (27). Detailed examination of MANF expression in the developing and adult mouse 
pancreas and islets revealed MANF expression in developing pancreatic primordium in E13.5 
embryo by immunohistochemistry (IHC) (Fig. 1A), when major differentiation of pancreas-specific 
endocrine cells begins (28). Consistent with our previous studies, we observed wide expression of 
MANF in adult mouse pancreas with positive signal in both exocrine acinar cells and endocrine 
islets of Langerhans (Fig. 1B) (22,29,30). Importantly, no positive signal was detected in the 
pancreas of Manf
-/-
 mice, confirming the specificity of MANF antibody used throughout this study 
(Fig. 1C-D, Supplementary Fig. 1.1D). QPCR and Western blotting analysis confirmed expression 
of Manf mRNA in pancreatic exocrine tissue and in isolated islets from adult mice (Fig. 1E-F). 
Thus, MANF protein is highly expressed in the mouse pancreas from early embryonic development 
until adulthood.  
Next we studied MANF expression in detail in different islet endocrine cells by IHC. Although the 
majority of MANF-positive cells were insulin-positive β-cells (Fig. 1G-I), weak MANF expression 
was also observed in δ-cells (Fig. 1K-M), while almost no MANF signal was detected in α- (Fig. 
1O-Q) or PP-cells (Fig. 1S-U). MANF was also co-expressed with cells expressing glucose 
transporter 2 (GLUT2) (Supplementary Fig. 1.1E-G) and pancreatic and duodenal homeobox 1 
(PDX1) (Supplementary Fig. 1.1H-J), further confirming that MANF is predominantly expressed in 
insulin expressing β-cells of the islets.  
Subcellular localization analysis revealed strong co-localization of MANF with the ER and insulin, 
a partial co-localization of MANF with GRP78 and a complete segregation of MANF from Golgi in 
the primary mouse islets cells based on the Mander’s and Pearson correlation coefficients (Fig. 1W-
Z, Supplementary Fig.1.1K-V, Supplementary Table 2).  
Interestingly, in pancreas tissue from diabetic mice, we found increased MANF expression in some 
β-cells located near lymphocytic cells invading the islets of 12-week-old pre-diabetic NOD mice 
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(Supplementary Fig. 1.2A-L). Barely no MANF expression was detected in the lymphocytic cells 
characteristic for insulitis. In addition, increased expression of MANF was found in some β-cells of 
8-week-old db/db mice (Supplementary Fig. 1.2M-Y). 










 mice  revealed that 
embryonic deletion of MANF specifically from the pancreas resulted in the postnatal β-cell failure 
(Supplementary Fig. 2.1 and Supplementary Text) (22). However, the decreased β-cell mass and 




 mice later than in the Manf
-/-
 mice 
(Supplementary Fig. 2.1 and Supplementary Text) (22). No ectopic Cre activity affected MANF 




 mice as compared to Manf
fl/fl
 mice (Supplementary 
Fig. 2.2A-J). Analysis of double transgenic Pdx-1Cre
+/-
::dtTomato reporter mice revealed that Pdx-
1Cre was not expressed in all MANF-expressing pancreatic cells during development or in adult 
islet endocrine and exocrine cells (Supplementary Fig. 2.2K-R and Supplementary Text). 




 mice leading to 
mosaic expression of MANF both in exocrine tissue and endocrine islets in the postnatal and adult 
pancreas (Supplementary Fig. 2.3A-I, K). Strong mosaic MANF expression was detected in P14 
and adult MANF conditional pancreases with individual degree of variation (Fig. 2F, 
Supplementary Fig. 2.3D-I). Some adult mice totally lacked MANF expression in the islets (Fig. 




 mice were significantly decreased at different postnatal stages, compared to Manf
fl/fl
 islets 
and the expression of Manf  mRNA in conditional islets increased with age (Supplementary Fig. 
2.3J).  Moreover, we observed loss of islet architecture and decreased intensity of insulin 
immunoreactivity in the pancreases lacking MANF (Fig. 2A-C, 2K, 2M, 2O), whereas islet 
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structure remained intact when MANF expression was present in most of the β-cells (Fig. 2D-F, 2J, 
2L, 2N). 
Furthermore, the number of double MANF- and insulin-positive cells correlated with the β-cell 
mass (Fig. 2P), and consequently with blood glucose levels in individual mice (Fig. 2Q). 
Quantification of TUNEL-positive insulin-positive β-cells revealed increased apoptosis in islets 
with increased number of β-cells lacking MANF (Fig. 2R).  





Reduced β-cell mass in P14 and P56 conditional animals was accompanied with a significant 
reduction of β-cells markers Glut2, insulin1/insulin2 (Ins1/2), Pdx1, MafA and  glucokinase (Gck) 




 mice (Fig. 3B-C, Supplementary Fig. 3A-C). This 
was expected since the proportion of β−cells compared to other islet cells, was decreased in the 
Pdx-1Cre+/-::Manf
fl/fl
  islets. No reduced expression levels of β-cell markers was observed in P1 
islets (Fig. 3A) in contrast to what was observed in the conventional Manf
-/-
 islets (22). Moreover, 
GLUT2 and MANF double immunohistochemistry confirmed that absence of MANF in the β-cells 
was associated with loss of GLUT2 membrane localization (Fig. 3F-N).  
UPR pathways are activated in isolated islets and pancreases from conventional Manf
-/-
 mice 
already before birth at E18.5 (20). Additionally, electron microscopy analysis of Manf
-/-
 β-cells 
revealed increased and expanded ER network with stacked and occasionally dilated sheets as a sign 
of ER stress in 4-week-old mice (Supplementary Fig. 3D-G, Supplementary Video1-2) (31-33).  
Consistent with this, we observed significant upregulation of Atf4, Grp78, Chop, spliced Xbp1 and 
total Xbp1, but not Atf6 mRNA levels in P1 conditional islets (Fig. 3D). At P14, we demonstrated 
continuous significant increase in mRNA levels of UPR markers (Fig. 3E). Altogether, activation of 
the main UPR sensors IRE-1, PERK and later ATF6 and their downstream targets seem to precede 




 conditional islets.  
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Effects of recombinant MANF protein in vitro  
We have previously demonstrated that recombinant human (rh)MANF protein stimulates 
proliferation of β-cells from young adult mice both in vitro and in vivo (22). Under normal 
conditions the primary mechanism for maintaining the postnatal β-cells mass is self-renewal of β-
cells (34). Basal β-cell proliferation and response to mitogenic triggers declines markedly with age 
in both rodents and humans (35-37). To realistically model the effect of MANF on adult human β-
cell dynamics we used islets from aged adult mice, where β-cell proliferation is extremely low. We 
found that rhMANF seem to increase β-cell proliferation rates in vitro even in islets isolated from 
aged, 15-month-old mice (Fig. 4A-J).   
We previously demonstrated that MANF partially protects mouse β-cells  from thapsigargin 
induced cell death in vitro (38). Herein, we analysed whether MANF protects isolated mouse islet 
β-cells from glucotoxicity. Manf mRNA levels were significantly upregulated in islets after 
exposure to hyperglycemia (Fig. 4K). In addition, we found increased expression of spXbp1 mRNA 
in the islets treated with high glucose consistent with previous results (Fig. 4M) (39,40). Addition 
of rhMANF in the medium containing high glucose led to a significant decrease in the expression 
levels of spXbp1 and tXpb1 mRNA (Fig. 4L-N). Furthermore, MANF protein was able to induce 
proliferation of Manf
-/-
 β-cells in vitro as well as significantly reduce the expression of UPR 
markers in isolated islets of Manf
-/-
 mice (Supplementary Fig. 4A-C).  






To address whether MANF is required for adult β-cell survival and proliferation in vivo we 





(TMX) mice did not differ in weight, but random fed TMX-injected conditional 
mice had increased blood glucose levels and reduced serum insulin levels accompanied by impaired 
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glucose clearance, as compared to control mice after 4 weeks wash-out period of TMX injections 





(TMX) animals, suggesting intact insulin sensitivity (Supplementary 
Fig. 5.1C). The lower insulin levels after intraperitoneal glucose injection confirmed decreased 




(TMX) animals (Supplementary Fig. 5.1D).  





mice was significantly lower compared to controls (Fig. 5E). Accordingly, islet insulin content was 
also reduced (Fig. 5F).  However, as shown for Manf
-/-
 islets, their capacity to secrete insulin 
relative to cellular insulin content did not differ from controls and the response to IBMX was even 
increased (Fig. 5G).  
Immunofluorescence staining revealed MANF expression in some β-cells four weeks after the 




 mice (Fig. 5K-M). The relative proportion of double 
MANF-and insulin-positive β-cells observed in islets of TMX-injected mice was 15.22 ± 3.27% 




(OIL) controls suggesting incomplete recombination 
with a degree of β-cell regeneration during the 4-week wash-out period following tamoxifen-





(OIL) islets (Fig. 5H-J, Supplementary Fig. 5.1F-W). This was in 










 mice suggesting some degree of leakiness resulting in Cre translocation to the 










(TMX) islets (Supplementary Fig. 5.1E). Importantly, TMX seemed to repress 
Manf mRNA expression by itself in Manf
fl/fl
 islets (Supplementary Fig. 5.1E). MANF expression in 
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mice (Supplementary Fig. 5.2A-J). 
Immunoperoxidase staining of pancreatic sections 4 weeks after TMX-injection revealed that lack 




(TMX) mice resulted in β-cell loss, decreased 
insulin expression and loss of islet architecture by redistribution of glucagon-stained α-cells into the 
core of islets (Fig. 5N-Q, Supplementary Fig. 5.1F-W). Significant reduction of the β-cell mass and 





(TMX) pancreases compared to the control groups (Fig. 5R, Supplementary Fig. 





(OIL) mice was 0.87 ± 0.08%, quantification of Ki67 positive insulin-positive β-





(0.45 ± 0.03%) (Fig. 5S). Additionally, the number of TUNEL positive insulin-positive β-cells were 









(OIL) (1.77 ± 0.11%) demonstrating increased  β-cell apoptosis 
in pancreases of adult mutant mice (Fig. 5T).  
Consistent with decreased β-cell mass in adult Manf-deleted mice, we found significant decrease in 





(TMX) mice compared to control islets (Fig. 6A).  In line with reduced expression 
of Glut2 and Pdx1 in islets we observed loss of GLUT2 membrane expression in β-cells where 
MANF was lacking (Fig. 6C-H).  Reduced nuclear PDX1 staining was also detected in islets 
deficient for MANF at adult age (Fig. 6I-N). Thus, expression of MANF in β-cells is essential to 
maintain β-cell phenotype and mass also in adult mice. 
MANF-deficiency in β-cells during development leads to increased and unresolved ER stress and 
chronic activation of the UPR response. In line with previous data, high levels of mRNA for Grp78, 
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(Fig. 6B). The level of sXbp1 and tXbp1 mRNA remained the same in both groups (Fig. 6B). 
Hence, increased and chronic activation of the UPR seem to be one of the mechanisms behind β-
cell failure after MANF-deletion also in mature adult β-cells.  
Insights in MANF mechanism of action 
Differences in cell signalling pathways between wild-type (Manf
+/+
) and MANF-deficient (Manf
-/-
) 
islets were studied in the presence or absence of rhMANF in vitro. Previous studies have suggested 
that MANF exerts its protective effect on neurons through activation of the PI3K/AKT signalling 
pathways (41). We found a trend for increase in AKT (Ser473) phosphorylation in Manf
+/+
 islets 
after MANF addition (Fig. 7A, 7B), besides a detectable but non-significant upregulation of pan-
AKT levels in MANF-treated islets (Supplementary Fig. 6C). A slight decrease in phospho-AKT 
was found in Manf
-/-
 islets, which was clearly though not significantly upregulated by addition of 
rhMANF (Fig. 7A, 7B, Supplementary Fig. 6C). Furthermore, Tribbles homolog 3 (Trib3) mRNA 
levels were significantly increased in MANF-deficient islets (Fig. 7C-D, Supplementary Fig. 6A).  
As Trib3 mRNA expression is modulated by ATF4 in the PERK-UPR pathway and TRIB3 is a 
negative regulator of AKT, the reduced AKT phosphorylation in Manf
-/-
 islets might be caused by 
the chronic activation of ATF4 followed by increased TRIB3 expression (5,42,43). We also found a 
trend for slight decrease in the level of phospho-ERK1 (44 kDa) in Manf
-/-
 islets compared to 
Manf
+/+ 
islets (Fig. 7E-F, Supplementary Fig. 6D). MANF has been shown to relieve NF-κB 
activation and downregulate BCL10 expression in human islets exposed to cytokines in vitro (30). 
As BCL10 is a known inducer of apoptosis and an upstream regulator of NF-κB signalling (44,45), 
we next tested whether NF-κB was differently regulated in β-cells in vitro. We found a trend for 
increased NF-κB phosphorylation in Manf
-/-
 islets compared to Manf
+/+ 
islets (Fig. 7G-H, 
Supplementary Fig. 6E). Furthermore, BCL10, a binding partner of TRAF2 and a regulator of NF-
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 islets at P1 (Fig. 7I,7J, 
Supplementary Fig. 6B). As IRE1α in prolonged ER stress forms a complex with apoptosis signal-
regulating kinase-1 (ASK1) and TNF receptor-associated factor 2 (TRAF2) triggering JNK 
activation (47), we tested c-Jun activation in the Manf
-/-
 islets. We observed a trend for increased 
phosphorylation of c-Jun (Ser63) in Manf
-/-
 islets compared to Manf
+/+
 controls (Fig 7K-L, 
Supplementary Fig. 6G). In addition to JNK, IRE1α stimulates the activation of p38MAPK that 
promotes apoptosis through phosphorylation of CHOP (48). A significant increase in levels of 
phospho-p38 was also detected in Manf
-/-
 islets compared to controls (Fig. 7M-N, Supplementary 
Fig. 6F). In rat β-cells, NF-κB induces expression of inducible nitric oxide synthase (iNOS) and NO 
production (47). We found a trend for increased iNOS expression in the Manf
-/-
 islets (Fig. 7O-P), 
thus suggesting NO production, inhibition of the SERCA-2b pump and depletion of Ca2
+
 from the 
ER increasing the amplitude of ER stress (47).  
DISCUSSION 
We recently reported that global absence of MANF in mouse results in insulin deficient 
diabetes and reduced viability (22). Herein, we provide new insights for the role of MANF during 
pancreas development and in mature β-cells.  
MANF expression in the developing and adult mouse was studied in detail revealing 
expression of MANF already in the endocrine pancreatic primordium during mouse embryonic 
development. Adult mouse pancreas exhibited MANF protein and Manf mRNA expression in both 
islets of Langerhans and pancreatic exocrine acinar cells. Importantly, in endocrine islets MANF 
was predominantly expressed in β-cells with some expression in δ-cells, but not in α- or PP-cells, 
comparable to results obtained in human islets (30). MANF protein levels are highly upregulated in 
pancreatic β-cells of Ins2
Akita
 mice, where UPR is triggered by the accumulation of misfolded 
proinsulin in the ER leading to β-cell death (29,49,50). Here we provide evidence that MANF 
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expression was increased in β-cells near infiltrated lymphocytes in pre-diabetic NOD islets, in 
agreement with data showing increased Manf mRNA expression and UPR activation preceding the 
β–cell death in islets from pre-diabetic NOD mice (51,52). Increased MANF expression was 
detected in some β-cells in the islets of db/db mice, in line with recently published data (53). 
Conversely, MANF was downregulated as a consequence of reduced Glis3 expression in β-cells 
diabetes-susceptible NOD mice, where chronic ER stress led to β-cell death (54). This study further 
support our results that MANF expression in β-cells is needed for restoring cellular homeostasis by 







 mice developed hyperglycaemia and 
hypoinsulinemia due to postnatal reduced β-cell mass caused by reduced β-cell proliferation and 





demonstrated patchy expression of MANF in both β-cells and exocrine acinar cells at P14 and 
onwards, suggesting clonal expansion of MANF-expressing cells in these pancreases. Importantly, 
ectopic Cre expression and recombination in the hypothalamic region of the brain of Pdx-1Cre
+/-
 





 brain suggesting that the diabetic phenotype is solely caused by the pancreatic 
deletion of MANF.  
We previously demonstrated that the β-cell mass is unaffected in E18.5 Manf
-/-
 mice, but 
decreased by 50% in new born Manf
-/-
 mice (22), suggesting that MANF is not needed for the 
development of β-cell mass before birth, but rather for the postnatal expansion of the β-cell mass. 
Here we demonstrated for the first time that the number of MANF-positive β-cells positively 










compared to conventional Manf
-/-
 mice was likely  due to an incomplete removal of MANF from 
the pancreas.  
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To directly address the role of MANF in mature β-cells, we specifically excised MANF from β-





(TMX) mice, we demonstrated that lack of MANF in the adult β-cells resulted 
in reduced expression of β-cell specific genes, poor β-cell survival and proliferation leading to 
hyperglycemia and diabetes. The above results strongly argue against a systemic effect of 
circulating MANF in rescuing β-cells and clearly demonstrates that local expression of MANF is 
required to maintain the β-cell phenotype in mice (56,57). Furthermore, MANF expression in 
pancreatic exocrine acinar cells did not protect MANF-deficient adult β-cells.  
The ability to stimulate adult β-cell proliferation and survival, inhibit β-cell apoptosis, and induce β-
cell neogenesis would significantly progress the prospects of therapy for diabetes. Currently, a 
number of different factors and hormones have been identified that induce β-cell proliferation in 
vitro or/and in vivo (58,59). However, not many can enhance the rates of β-cell proliferation and 
restrain β-cell apoptosis at the same time.  In this study, we demonstrated that MANF protein was 
able to intensify islet β-cell proliferation from aged mice, suggesting that MANF could partly 
reverse age-dependent repression of β-cell replication. Previously, we found that recombinant 
MANF protein partially rescued mouse and human β-cells from cytokine and ER stress-induced cell 
death in culture (30,38) and induced human β-cell proliferation (30). Here we showed that Manf 
mRNA was upregulated in mouse β-cells in hyperglycemic conditions in vitro and that MANF 
protein reduced ER stress-induced glucotoxicity in mouse β-cells.  We showed that MANF protein 
induced β-cell proliferation and reduced ER stress in MANF-deficient islets. Previously we showed 
that inflammatory cytokines were able to increase MANF-secretion from human β-cells in vitro 
(30). These results strongly indicate that exogenous MANF acts in a paracrine manner by 
dampening ER stress thus favouring β-cell protection and proliferation. 
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It is still unknown how and where MANF exerts its beneficial effects. We show that it resides in the 
ER where it modulates ER stress and is crucial for β−cell survival. Upon ER stress, MANF is 
secreted from β−cells (30) and rhMANF have protective and restorative effects when applied 
exogenously to human and mouse β-cells (30,38). Thus MANF seems to have a dual mode of action 
1) co-translationally inserted in the ER modulating ER stress and 2) extracellularly (possibly via 
autocrine/paracrine signaling) activating a signal transduction pathway or/and by being endocytosed 
and transported to the ER.   
The identification of signaling receptors for MANF has been challenging. MANF with its 
suboptimal ER retention signal in its C-terminal domain, was found to weakly bind to KDEL 
receptor in the ER (20). The same study suggested that MANF also binds KDEL receptors at the 
cell membrane of cell-lines overexpressing KDELRs (20). However, direct binding of MANF to 
KDELR was not confirmed. Recently, MANF was reported to bind to lipid sulfatides (e.g. 3-O-
sulfogalactosylceramide) located at the outer leaflet of cell membranes in C. elegans and in 
mammalian cells following MANF uptake by endocytosis into the cells (21). This report suggested 
that sulfatides are important for MANF cell surface binding, transport and secretion (21). The N-
terminal domain of MANF contains a saposin-like domain known to be able to bind lipids (60). In 
addition, in the pancreas, sulfatides are selectively synthesized in β−cells but not in pancreatic 
exocrine tissue (61). Thus, exogenous MANF might be taken up by β−cells through lipid sulfatide 
binding and endocytosed back to ER where it relieves ER stress leading to restored proliferation 
and/or protection from ER stress-induced apoptosis. However, the increased mitogenic effect of 
MANF on β-cells might still depend on yet unidentified signaling receptor(s) and signaling 
cascades.  
Previously we demonstrated the activation of all three UPR branches in pancreatic islets in Manf 
-/-
 
mice (22). Herein we confirmed that  chronic UPR activation and persistent ER stress in islets 
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lacking MANF is one of the mechanisms behind the reduced β-cell proliferation and increased β-








(TMX) mice. In 
addition, we showed a trend to decreased AKT phosphorylation and increased activation of 
inflammatory signalling in Manf
-/-
 islets, probably caused by chronically activated UPR pathways. 
In agreement, we recently reported that MANF relieves cytokine-induced β-cell death through NF-
κB inhibition in human β−cells (30). In addition, MANF was implicated as a negative regulator of 
inflammation by inhibiting expression of NF-κB target genes in the nucleus of fibroblast-like 
synoviocytes (62). Interestingly, platelet-derived growth factor (PDGF) released from injured retina 
promoted MANF expression in innate immune cells, and biased cells towards anti-inflammatory 
phenotype thereby promoting retinal tissue repair in mouse and fruitfly (63). Thus, roles for MANF 
in inflammation is emerging. In this study we have provided evidence for a mechanistic link 
between chronic ER stress and increased inflammation leading to β-cell death in Manf
-/-
 islets (Fig. 
7Q). A modest activation of the UPR has been suggested to adapt β-cells to the high demand of 
insulin production (10,64). Therefore, reduced insulin production by knockdown of insulin 2 gene 
in Ins1
-/- 
background in adult mouse β-cells resulted in decreased PERK/eIF2α (65). The decrease in 
UPR led to an increase in proliferation through upregulation of the AKT/Cyclin D1 axis caused by a 
decrease in Trib3 expression, suggesting that increased UPR signalling through peIF2α reduces β-
cell proliferation. Similarly, addition of MANF to ER stressed β-cells might reduce ER stress and 
lead to increased β-cell proliferation.  A recent study revealed that genetically-induced MANF 
overexpression in the hypothalamus led to increased feeding behavior and obesity in mice, caused 
by impaired insulin signaling and insulin-resistance in the hypothalamus (66). In contrast, decreased 
MANF-expression in the hypothalamus resulted in hypophagia and reduced body weight. Increased 
MANF at the ER was suggested to recruit and activate PIP4k2b, thus reducing AKT 
phosphorylation downstream of insulin receptor signaling leading to the hyperphagia (66). This 
result suggests that the cellular MANF levels are critical for insulin regulated AKT 
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phosphorylation. Thus, MANF-deficiency seems to result in ER stress, increased 
PERK/pEIF2α signaling, selective ATF4 translation inducing Trib3 expression leading to reduced 
AKT phosphorylation and proliferation.  
In conclusion, deletion of MANF from mouse β-cells both in early pancreatic development and in 
adulthood results in insulin-deficient diabetes. Consequently, endogenous MANF levels in β-cells 
correlates with β-cells survival in normal, diabetes-susceptible and stressed β-cells, but the precise 
mechanisms of MANF action needs further investigation. The ability of MANF to induce 
proliferation and at the same time protect β-cells from death makes it a promising drug candidate 
for the treatment of diabetes. 
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Figure 1. MANF is specifically expressed in the β-cell of the islets of Langerhans.  
(A-D) Immunohistochemical localization of MANF protein in pancreatic primordium at E13.5 in 
Manf 
+/+
 embryo (A), and in adult Manf 
+/+
 mouse pancreas (B), using  sections from E13.5 Manf
 -/-
 
embryo (D), and adult Manf
 -/-
 mouse pancreas (D) as specificity controls for  anti-MANF antibody 
(Icosagen). Scale bar, 50 µm.  
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 (E) Quantitative RT-PCR analysis for Manf mRNA levels in islets of Lagerhans isolated from 
Manf 
+/+
 mice (n = 6) and exocrine tissue (n = 3) from Manf 
+/+
 mice at P56. Values represent mean 
± SEM, *p < 0.05, **p < 0.01, ***p< 0.001, ns. –not significant.  
(F) Western blot analysis of lysates from isolated islets confirms that MANF protein is not 
expressed in islets from Manf
-/-
mice. Recombinant human MANF protein (15 ng MANF) was used 
as positive control and anti-GAPDH antibody for normalization of total protein content. 
(G-V) Double immunohistochemistry analysis with anti-MANF antibody  (H, L, P, T) and 
antibodies against other islet hormones, insulin (G), and somatostatin (K), glucagon (O), PP (S). 
MANF (red) was co-expressed with insulin in β-cells (green) and weakly with somatostatin in δ-
cells (green). Almost no MANF signal was detected in α-(green) or PP (green) cells. Very weak or 
no MANF positive staining was observed in Manf
-/-
 pancreatic islets (J, N, R, V). Cell nuclei were 
labelled with DAPI (blue). Scale bar, 10 µm. 
(W-Z) Representative confocal laser scanning microscopy images of primary mouse islet β-cells 
double-stained with anti-MANF (red) and anti-PDI (protein disulphide isomerase, ER marker, 
green), anti-GM130 (Golgi marker, green), anti-insulin (green) or  anti-GRP78 (green) antibodies. 
Scale bar, 8 µm. Quantitative co-localization analysis based on Pearson's correlation coefficient and 
Mander’s coefficients (shown in the Supplementary Table 2) revealed high co-localization of 
MANF with ER marker PDI and insulin, moderate co-localization with GRP78 and no co-
localization of MANF with Golgi marker GM130. 
 
Figure 2. MANF expression in β-cells is important for restoring the β-cell mass. 
(A) Insulin (A, D, G), glucagon (B, E, H) and MANF (C, F, I) immunohistochemistry on 




 mice. Scale bar, 50 µm. 
(J-O) Double immunohistochemistry with anti-insulin (green) (J, K) and anti-MANF antibodies 




 mice. Cell 
nuclei in merged picture (N-O) labelled with DAPI (blue).  Scale bar, 20µm.  




 mice positively correlates with the number of  MANF 
positive insulin-positive cells, n = 15. 
 (Q) The number of MANF positive insulin-positive cells negatively correlates with the blood 




 mice, n = 18. 
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 (R) The fraction of MANF-positive insulin-positive β-cells negatively correlates with the number 




 mice, n = 11. 
 
Figure 3. MANF expression is required for maintaining the β-cell mass. 
 (A-C) Quantitative RT-PCR for mRNA levels of β cell-specific genes Glut2, Ins1/2, Pdx-1, Gck 
and MafA in islets from P1 (A), P14 (B), and P56 (C) pancreases, n = 6-11 per group .  
(D-E) Quantitative RT-PCR PCR analysis of UPR genes Atf4, Grp78, Chop, spliced (sp)Xbp1, total 




 and  Manf
fl/fl 
mice. n = 6-11 per group. 
(F-N) Double immunohistochemistry of MANF (red) (I-K) and GLUT2 (green) (F-H) in pancreatic 
sections from Manf
fl/fl




 (G-H, J-K, M-N) mice at P56. Cell nuclei 
were labelled with DAPI (blue).   Scale bar, 10 µm. 
Values represent mean ± SEM, *p < 0.05, **p < 0.01, ***p< 0.001. 
 
Figure 4. Effects of MANF in vitro  
 (A) Recombinant MANF protein increases proliferation of β-cells from aged 15-month-old female 
C57BL/6 Rcc mice after 5 days in culture. n =quantified from 4-6 wells per group. The proliferative 
effect of MANF in a second experiment using 15-month-old female Hsd:ICR(CD-1) mice was 0.44 
± 0.067% compared to 0.25% ± 0.034% in control islets showing a similar significant increase in β-
cell proliferation in the MANF-treated islets (data not shown).  
(B-J) Double immunohistochemistry of insulin (B, E, H) and Edu (C, F, I). Cell nuclei were 
labelled with DAPI (blue).   Scale bar, 50 µm. 
(K-N) Quantitative RT-PCR PCR analysis of UPR genes Manf, Grp78, spliced (sp)Xbp1 and total 
(t)Xbp in primary mouse pancreatic islets treated with 30mM (+)  glucose or non-treated (-) without 
(-) or with recombinant human MANF (+) overnight in RPMI medium supplemented with 0.5% 
BSA. n = 4-5 wells per group. 
Values represent mean ± SEM, *p < 0.05, **p < 0.01, ***p< 0.001. 
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mice.   






 animals 4 weeks after last TMX 
injection, n =11-12 mice per group, both genders.  
(B) Ad libitum-fed blood glucose levels measured 4 weeks after last TMX injection, n = 
11-12 mice per group, both genders. 
(C) Serum insulin levels measured 4 weeks after TMX injection from ad libitum-fed mice, 
n = 11-12 mice per group, both genders.  
(D) Blood glucose levels measured after intraperitoneal glucose (2 g/kg) injection, n = 5-
12 mice per group. 
(E-G) In vitro insulin release from islets in response to low glucose (1.67 mmol/l; G1.67), high 
glucose (16.7 mmol/l; G16.7), and high glucose with IBMX (1 mmol/l), normalized to islet DNA 
content after 1 hr (E).Total insulin content normalized to islet DNA content (F). In vitro glucose-
stimulated insulin release compared to total islet insulin content (G), n = islets from six 
pancreases/group. 
(H-M) Recombination efficiency is varying in individual mouse showing different amount of 





 mice injected with TMX with anti-insulin (L) (green) and anti-MANF 
antibodies (M) (red). Cell nuclei were labelled with DAPI (blue).   Scale bar, 50 µm. 
(N-Q) Immunohistochemical analysis of insulin- (N, O) and glucagon-positive (P, Q) cells in 




injected with TMX compared to those injected with oil. Scale bar, 50 µm. 




mice injected with TMX, 




mice injected oilmice, n = 4-5 mice per 
group, both genders. 
(S) β-cell proliferation assessed by Ki67 and insulin staining, n =6 mice per group. 
(T)  β-cell apoptosis assessed by TUNEL and insulin staining, n =6 mice per group. 
Mean ± SEM, *p < 0.05, **p < 0.01, ***p< 0.001 versus the corresponding control.  
 
Figure 6. MANF expression in β-cells is essential for maintaining the adult β-cell mass. 
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(A)  Quantitative RT-PCR for mRNA levels of β cell-specific genes Glut2, Ins1/2, Pdx-1, 




 injected with oil (white bars) and tamoxifen 
(black bars). n = islets from 7-9 mice per group. 
(B) Quantitative RT-PCR PCR analysis of UPR genes Atf4, Grp78, Chop, sXbp1, tXbp, 




 injected with oil (white bars) and 
tamoxifen (black bars). n =islets from 7-9 mice per group. 
(C-H) Double immunohistochemistry of MANF (red) (D, G) and GLUT2 (green) (C, F) in 




mice injected with oil and tamoxifen. Scale 
bar, 10 µm. 





injected with oil or tamoxifen. Scale bar, 10 µm. 
Mean ± SEM, *p < 0.05, **p < 0.01, ***p< 0.001 versus the corresponding control.  
Figure 7. Insights in MANF mechanism of action 




 mice in the 
presence or absence of recombinant MANF   (A, E, G, K, M, O). Western blotting with indicated 




 mice, non-treated (-) or treated (+) with 
recombinant MANF. Quantified intensities of western blot bands of  phospho-AKT (Ser 473) 
compared to the total amount of AKT (B), phospho-ERK1/2 to total ERK1/2 (F), phospho-NF-κB 
p65 (Ser536) to total NF-κB p65 (H), phospho-c-Jun (Ser63) to total c-Jun (L),  phospho-p38 to 
total p38 (N) and iNOS compared to GAPDH (glyceraldehyde 3-phospate dehydrogenase) (P). n 







 mice at postnatal days 1 (P1) and 14 (P14) (C) and 




 mice (D), n = islets from 4-6 mice per group. 












 mice (J), n = islets from 4-6 mice per group. ns., non-
significant. Mean ± SEM, *p < 0.05, **p < 0.01, ***p< 0.001 versus the corresponding control.  
(Q) A link between ER stress and inflammation in MANF-deficient mouse pancreatic β-cells. 
MANF deficiency in β-cells leads to ER stress and activation of all three UPR branches, ATF6, 
PERK and IRE1α. Transcription factor ATF4, which escapes the translational inhibition induced by 
pEIF2α in the PERK pathway, increases Trib3 expression. TRIB3 is known to block AKT 
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phosphorylation and thereby inhibits insulin signalling and β-cell cycle progression (62). 
Expression of CHOP, a pro-apototic transcription factor is induced by both cleaved ATF6 and 
ATF4. IRE1α activation results in activation of JNKs, NF-κB and p38MAPK inflammatory 
signalling cascades contributing to the increased expression of several pro-apoptotic genes 
including Bcl10, which is a known inducer of apoptosis and regulator of NF-κB. Nuclear NF-κB 
activation leads to increase iNOS production which contributes to increased NO production. NO has 
been found to inhibit the SERCA-2b pump and thereby contributes to depletion of Ca
2+
 from the ER 
leading to increased ER stress (46). Abbreviations: ER, endoplasmic reticulum; ATF, activating 
transcription factor; PERK, protein kinase R-like endoplasmic reticulum kinase; IRE1, inositol-
requiring enzyme; NF-κB, nuclear factor κ-light-chain-enhancer of activated B cells; JNK, c-Jun N-
terminal kinases, iNOS, inducible nitric oxide synthase: NO, nitric oxide; BCL10, B-cell 
lymphoma/leukemia 10; IΚB, inhibitor if κB kinases; SERCA2b, sarcoplasmic/endoplasmic 
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Supplemental text 
 
Analysis of Pdx-1 Cre recombinase activity  
Pdx-1 Cre recombinase activity was examined by crossing Pdx-1Cre
+/-
 mice to tdTomato reporter 
mice. We detected Cre-mediated tdTomato expression in the pancreas, but also in duodenum and 
liver at different embryonic and postnatal stages (Supplementary Fig. 3.1K-DD). In embryonic and 
early postnatal pancreas development MANF was found to be expressed in most cells with the 
highest expression in endocrine cells (Supplementary Fig. 3.1K-M, O-Q).  
Pancreas-specific ablation of MANF leads to diabetes in mice  
The absence of MANF from conventional Manf 
-/-












mice do not show growth retardation (Supplementary Fig. 2.1B), suggesting that MANF-removal 
from other cells rather than β-cells  results in the growth defect in conventional Manf
-/-
 mice. A 




 mice, when animals already 






  mice developed diabetes 
later. Blood glucose and serum insulin levels were within the normal range in P1 and P14 random 
fed animals (Supplementary Fig. 2.1C-D). However, severe hyperglycaemia and significant 
reduction in serum insulin levels were observed in random fed P56 conditional mice 
(Supplementary Fig. 2.1C-D). Glucose tolerance test revealed impaired glucose clearance and a 




 compared to 
controls (Supplementary Fig. 2.1E-F). As reported for Manf
-/-
 mice (1), insulin tolerance test 




 conditional mice revealed intact insulin sensitivity 
(Supplementary Fig. 2.1G).  
  Histological analysis of pancreases revealed marked loss of islet architecture and reduced insulin 




 mice (Supplementary Fig. 2.1I-N, 2.1O-T). Quantification of 





 pancreases  compared to controls (Supplementary Fig. 2.1U). Consequently, 




 pancreases was reduced (data not shown), indicating β-
cell loss. Consistent with our data with global Manf
-/-
 mice, lack of MANF from the pancreas 
resulted in a significantly reduced number of Ki67 positive β-cells starting at P14 (Supplementary 
Fig. 2.1W). The reduction of the β-cell mass was also accompanied by increased levels of β-cell 
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apoptosis in P14 and P56 pancreases from conditional mice quantified by TUNEL assay 
(Supplementary Fig. 2.1X, 2.1Y-DD). 
Supplemental Experimental Procedures 
Animals and in vivo physiology 
In brief, Manf
fl/fl
 mice were produced by removing the β-galactosidase reporter cassette preceded by 
a strong splicing acceptor by crossing Manf
+/-
 mice with ubiquitous Flp expressing CagFlp mice (1) 
and (Supplementary Fig. 2.1A).  
Pdx-1Cre recombinase activity was evaluated by crossing Pdx-1Cre mice with Rosa26-
tdTomato
fl/Stop/fl
 reporter mice (Jackson Laboratories, Stock 007914).  
Collected blood samples from the mice were assayed for glucose (Accucheck Aviva Glucometer; 
Roche Diagnostics) and sera for insulin (ultrasensitive mouse insulin ELISA; Crystal Chem) 
measurements. DNA isolation and genotyping of mice were carried out as described previously 
(1,2) and in Supplementary Data. 
 
Genotyping primers and expected PCR products  
DNA was isolated from ear-marks and genotyping was carried out. For  MIP-1Cre
ERT 
mice the 
following primers were used: Forward (transgene) 5’-TGGACTATAAAGCTGGTGGGCAT-3’, 
Reverse (transgene) 5’-TGCGAACCTCATCACTCGT-3’, Internal Positive Control Forward 5’-
CTAGGCCACAGAATTGAAAGATCT-3’, Internal Positive Control Reverse 5’-
GTAGGTGGAAATTCTAGCATCATCC-3’ (PCR products: Transgene = ~230 bp, Internal 
positive control = 324 bp). For Rosa26-tdTomato
fl/Stop/fl
 reporter mice the following primers were 
used: Wild type Forward 5’-AAGGGA GCT GCA GTG GAG TA-3’, Wild type Reverse 5’-CCG 
AAA ATC TGT GGG AAG TC-3’, Mutant Reverse 5’-GGCATTAAAGCAGCGTATCC-3’, 
Mutant Forward 5’-CTGTTCCTG TACGGCATGG-3’ (PCR products: Mutant  = 196 bp, 
Heterozygote = 297 bp and 196 bp, Wild type = 297 bp).  
 
Histological Analysis  
Islet-cell mass was assessed from pancreatic sections stained with anti-Chromogranin A antibody 
and quantified similarly to beta cell mass described previously (1). 
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For identification of LacZ activity cryosections were stained with X-gal solution as described 
previously (3).tdTomato expression was detected in cryosections as described previously (4) and 
followed by staining with anti-MANF antibody and DAPI. 
Fluorescence or light microscopy images were captured with 3DHISTECH Panoramic 250 FLASH 
II digital slide scanner (Budapest, Hungary, with scanning service in the Institute of Biotechnology 
and in Research Programs Unit, Faculty of Medicine, University of Helsinki, Biocenter Finland) or 
Zeiss AxioImager M2 482 epifluorescence microscope equipped with 483 AxioCam HRm camera. 
Images were analysed with Pannoramic viewer program or acquired with the AxioVision4 software.  
 
Subcellular localization analysis 
Islets from C57BL/6Rcc pancreases were isolated and cultured overnight in the RPMI1649 medium 
supplemented with 10% Fetal Bovine Serum and a mixture of antibiotics. Next day islets were 
dissociated  with Tryple
TM
 Select Enzyme (Cat.number 12563011, Thermo Fisher Scientific, 
Waltham MA, USA), followed by centrifugation onto glass slides. Cells were fixed and stained for 
different primary antibodies (Supplementary Table 1). Appropriate secondary antibodies conjugated 
with Alexa Fluor® 488 or 568 (1:400, Molecular Probes, Life Technologies, Eugene, Oregon, 
USA) and DAPI (Vectorshield, Vector laboratories, Burlingame, USA) were used to visualize the 
labels. 
Slides were imaged with PerkinElmer Opera Phenix high-content confocal microscope using 
Harmony 4.6 software (PerkinElmer), by using three lasers with excitation wavelengths 405nm, 
488nm, and 568nm. 63x water immersion objective (NA 1.15) was used for imaging. The lateral 
pixel size was automatically set to 95nm and the distance between axial slices was set to 500nm 
according to the Nyquist criterion. Altogether 10-14 optical sections were recorded using 16-bit 
Andor Zyla CMOS camera (2160x2160 px). 125 and 49 fields-of-view were recorded from the first 
and second set of slides, respectively. 
The colocalization analysis was performed in 3D for each cell separately. Densely packed and 
malformed cells were filtered out from the analysis. First, nuclei and cells were segmented from 2D 
maximum intensity projection images using Harmony software. Next, linear classifier was trained 
to classify cells into two classes: isolated and packed/malformed. Last, the 2D coordinates of 
isolated cells were exported from Harmony software. The rest of the analysis was carried out in 3D 
using BioImageXD software (5). Cells were segmented in 3D using combination of Hoechst and 
Page 37 of 61 Diabetes
MANF (568nm) channels. Only the cells overlapping with the exported 2D coordinates of isolated 
cells were used for colocalization analysis. For each cell, both Pearson correlation coefficient for 
overall signal correlation and Manders' coefficients (6) for channel specific colocalization were 
measured. The total number of analysed cells varied from 20 to 66. 
 
Western Blotting 
Western blotting analysis was performed using standard protocols and as described previously (1). 
For primary antibodies see Supplementary Table 1. 
 
Islet isolation, In Vitro Insulin Release and In Vitro Islets experiments 
Islet isolation and in vitro insulin release from islets were performed as described previously (1,7). 
In brief, pancreases were digested by collagenase P (Collagenase P; Roche Diagnostics) using 
standard protocol procedure and islets were purified from acinar tissues by handpicking them up 
under a microscope.  
In order to test the effect of human recombinant MANF on ER stress in MANF-deficient islets we  




 mice for 24 h with or without MANF 
(1µg/ml, Icosagen) in 0.5% bovine serum albumin (BSA) in RPMI medium directly after islets 
isolation or with MANF (100ng/ml, Icosagen) for 3 days in 10% FBS RPMI medium, changing 2/3 
of the medium into fresh every day. 
To test the effect of MANF on mouse islets exposed to hyperglycaemia, isolated islets from 12- 
week-old C57BL/6Rcc mice were cultured in RPMI medium (glucose 11mM) supplemented with 
0.5% BSA in the presence and absence of high levels of glucose (30mM) overnight with or without 
MANF 1µg/ml. 
 
Analysis of Blood Samples by glucose tolerance test (GTT), insulin tolerance test (ITT), and by 
glucose challenge test (GTT). 
Analysis of blood samples were performed as described previously (1). 
 
RNA Isolation, Reverse Transcription, and Quantitative RT-PCR 
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RNA Isolation, reverse transcription, and quantitative real-time polymerase chain reaction (QPCR) 
were performed as described previously (1). Primer sequences for the gene expression studied by 
QPCR have been described previously (1). Other primer sequences: mouse Bcl10 Forward 5’-AAA 
CTG GAG CAC CTC AAA GG -3’, mouse Bcl10 Reverse 5’-TCT CAT CGG AAT TGC ACC TA 
-3’, mouse Trib3 Forward 5’- CGC TTT GTC TTC AGC AAC TGT-3’, mouse Trib3 Reverse 5’-
TCA TCT GAT CCA GTC ATC ACG -3’. 
 
Serial block-face scanning electron microscopy (SB-EM)  
The dissected tissues (<2 mm x 2 mm blocks) were stained using an enhanced staining protocol (8). 
First, the tissues were fixed with 2.5% glutaraldehyde and 2% formaldehyde, in 100 mM Na-
cacodylate buffer (pH 7.4) supplemented with 2 mM CaCl2 for 2 hours. Stained and dehydrated 
specimens were embedded into Durcupan ACM resin (Merck Sigma-Aldrich, Darmstadt, 
Germany), that was mixed according to the manufacturer's recommendations. The embedded tissue 
was trimmed to a pyramid and mounted onto a pin using conductive epoxy glue (model 2400; 
CircuitWorks, Kennesaw, GA). Finally, the sides of the pyramid were covered with silver paint 
(Agar Scientific Ltd, Stansted, UK), and the whole assembly was platinum coated using Quorum 
Q150TS (Quorum Technologies, Laughton, UK). SBEM data sets were acquired with an FEG-SEM 
Quanta 250 (Thermo Fisher Scientific, FEI, Hillsboro, OR), using a backscattered electron detector 
(Gatan Inc., Pleasanton, CA) with 2.5-kV beam voltage, a spot size of 3, and a pressure of 0.15-0.30 
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Supplementary figures and supplementary figure legends 
Supplementary Figure 1.1 
 
 
Supplementary Figure 1.1, supporting Figure 1. MANF is specifically expressed in the β-cell 
of the islets of Langerhans.  
Detection of β-galactosidase activity under the control of MANF promoter in E12.5 pancreatic 
primordium and adult pancreas was detected by X-gal staining in Manf
+/-
 heterozygote chimeric 
animals. (A, B) LacZ stained (blue) cryosections counterstained with nuclear fast red (pink) from 
Manf 
+/-
 chimeric embryo at E12.5 (A) and from adult Manf 
+/-
 chimeric pancreas (B). Scale bar, 
100 µm. 
(C-D) Immunohistochemical localization of MANF protein in Manf +/+ (C) and in Manf -/- (D) 
pancreas as negative control by using anti-ARP (MANF) antibody (Santa Cruz). Scale bar, 100 µm.  
Page 41 of 61 Diabetes
(E-J) Double immunohistochemistry analysis with MANF (F, I) GLUT2 (E), and PDX1 (H). 
Nearly all MANF positive cells (red) expressed GLUT 2 at the cell membrane of  β-cells (E-G)  
whereas all MANF-positive cells showed nuclear staining for PDX1 (green) (H-J). Cell nuclei were 
labelled with DAPI (blue). Scale bar, 10 µm.  
(K-V) Representative confocal laser scanning microscopy images of double immunocytochemistry 
analysis of primary mouse β-cells using anti-MANF antibody (red) (K-R) with anti-PDI (Protein 
Disulphide Isomerase, ER marker, green) (K, S), anti-GM130 (Golgi marker, green) (L, T), anti-
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Supplementary Figure 1.2 
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Supplementary Figure 1.2, supporting Figure 1. MANF expression in the β-cells of diabetic 
mouse models NOD and db/db. 
(A-F) MANF (A, D), insulin (B, E) and glucagon (C, F) immunohistochemistry on pancreas 
sections from 11-week-old NOR (A, B, C) and NOD (D, E, F) mice. Scale bar, 20 µm.  
(G-L) Double immunohistochemistry on pancreatic sections from 11-week-old NOR and NOD 
mice with anti-MANF (green) (G, J) and anti-insulin antibodies (red) (H, K) show increased 
MANF expression in β-cells in the periphery of islets near lymphocytic inflammatory cells invading 
the islets. Cell nuclei in merged pictures (I, L) labelled with DAPI (blue).  Scale bar, 50µm.  
(M-S) MANF (M, Q), insulin (N, R) and glucagon (O, S) immunohistochemistry on pancreas 
sections from 8-week-old db/+ (M, N, O) and db/db (Q, R, S) mice. Scale bar, 20 µm.  
(T-Y) Double immunohistochemistry with anti-MANF (green) (T, W) and anti-insulin antibodies 
(red) (U, X) revealed disturbed islet architecture (W, X) and increased expression of MANF in 
some db/db islet β-cells (X) whereas others appeared to have reduced expression compared to 
MANF-stained β-cells in the control db/+ islets in 8-week-old mice. Cell nuclei in merged picture 
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Supplementary Figure 2.1 
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Supplementary Figure 2.1, supporting Figure 2. Absence of MANF in pancreas results in 
diabetes in Pdx-1Cre+/-::Manffl/fl mice.  
(A) Schematic representation of the Manf+/+wild-type, Manf-/-, Manfflox/flox(fl/fl) and 
Cre::Manf 
fl/fl
 targeted allele. The strong splice-acceptor and β-galactosidase cassette was removed 
by crossing of Manf 
+/-
 to CAG-Flp transgenic mice in order to produce Manf
fl/fl
 mice, where exon 3 
is flanked with LoxP sites enabling removal in Cre-expressing cells. β-galactosidase reporter 
cassette (β-gal), strong splicing acceptor site (En2SA), exon (E), Frt (F)-sites, LoxP (L)-sites, 
βAct::Neo; human β-actin promoter driven neomycin resistance gene. 
(B) Growth curve of Manffl/fl and Pdx-1Cre+/-::Manffl/fl littermates. P1–P56, n =5-18 per group, 
combined from both sexes.  
(C) Ad libitum-fed blood glucose levels, n=9-21 per group; 
(D) Serum insulin levels from ad libitum-fed mice, n = 9–15 per group; 
(E) Blood glucose levels measured after intraperitoneal glucose (2 g/kg) injection, n =8-9 mice per 
group.  
(F) Serum insulin levels in P56 mice measured 30 min after glucose (2 g/kg) bolus injection, n =7 
mice per group.  
(G) Blood glucose levels measured after intraperitoneal injection of insulin (1 U/kg), n =7-8 mice 
per group.  
   (I-N) Insulin immunohistochemistry on pancreas sections from Manffl/fl (I-K) and Pdx-1Cre+/-
::Manf
fl/fl
    (L-N) animals at P1 (I, L), P14 (J, M), and P56 (K, N). The scale bar represents 20 µm. 
(O-T) Insulin (O-Q) and glucagon (R-T) immunohistochemistry on pancreas sections from P56 
Pdx-1Cre, Manf
fl/fl and Pdx-1Cre+/-::Manffl/fl mice. Scale bar, 50 µm. 
(U) Reducedβ-cell mass in Pdx-1Cre+/-::Manffl/fl mice from P14, n = 6-20 per group. 




 mice, n = 5-7 per group. 
(W) β-cell proliferation assessed by Ki67 and insulin staining, n =5-12 per group. 
(X) β-cell apoptosis assessed by TUNEL and insulin staining, n =5-12 per group. 






 pancreases at P56 using TUNEL (green)- and anti-insulin (red) staining. Arrowheads 
point to TUNEL-positive β-cell (R). Scale bar 50 µm.  
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Values represent mean ± SEM, *p < 0.05, **p < 0.01, ***p< 0.001. 
 
Supplementary Figure 2.2 
 
 
Supplementary Figure 2.2, supporting Figure 2. Analysis of Pdx-1 Cre recombinase activity  
(A-J) MANF immunohistochemistry on brain sections from Manf
fl/fl
 (A-E) and Pdx-1Cre
+/-   
::Manf
fl/fl
  mice  (F-J). No visible differences were observed in MANF expression in the cortex (A, 
F), hippocampus (B, G), paraventricular nuclei of hypothalamus (PVN) (C, H), dorsal medial 
nuclei of hypothalamus (DMH) (D-I) and supraoptic nuclei of hypothalamus (E, J). Scale bar, 
50µm. 
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(K-R) Co-expression of MANF and tdTomato red fluorescent protein. Double 
immunohistochemistry analysis of MANF (green) and tdTomato (red) expression in the pancreases 
of Pdx-1Cre
+/-
::tdTomato (K-N) and tdTomato mice (O-R). dtTomato expression was observed in 
developing pancreatic primordium at E12.5, when high MANF signal was detected in some cells of 
the pancreatic primordium probably representing insulin-positive cells (K). At E18.5 (L) Tomato 
expression was detected in the islet nuclei of MANF positive cell. At P3 (M) and P56 (N) Tomato 
expression was found in the nuclei of endocrine islets and in exocrine tissue mostly overlapping 
with MANF expression. However, some MANF-positive cells lacked Tomato expression, 





 mice. Notably, no Tomato signal was observed in the tdTomato 
mice lacking Cre, indicating that the system is not leaky (O-R). Cell nuclei were labelled with 
DAPI (blue). Scale bar, 100 µm. 
(J-Q) Merged pictures of double immunohistochemistry analysis with MANF and Tomato 
expression in the duodenum region of the intestine of Pdx-1Cre
+/-
::tdTomato (S-V) and tdTomato 
mice (W-Z). MANF and Tomato expression was observed in developing intestine at E12.5 (S). At 
E18.5 (T), P3 (U), P56 (V) Tomato expression was detected in the villi of duodenum with mosaic 
expression pattern. Notably, no positive Tomato signal was observed in the tdTomato mice, 
indicating the specificity of the expression pattern in Pdx-1Cre
+/-
::tdTomato (W-Z). Cell nuclei 
were labelled with DAPI (blue). Scale bar, 100 µm. 
(AA-DD) Merged pictures of double immunohistochemistry analysis with MANF and Tomato 
expression in the liver of Pdx-1Cre
+/-
::tdTomato (AA, BB) and tdTomato mice (CC, DD). 
Surprisingly, few positive Tomato cell were detected in the liver of P3 (AA) and P56 (BB) in Pdx-
1Cre
+/-
::tdTomato. However, no positive Tomato expression was observed in E18.5 (R, U). 
Notably, no positive Tomato signal was observed in the tdTomato mice, indicating the specificity of 
the expression pattern in Pdx-1Cre
+/-
::tdTomato (CC, DD). Cell nuclei were labelled with DAPI 
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Supplementary Figure 2.3 
 





  mice is highly variable between individual mice  
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 (B-C, E-F, H-I) mice at P1 (A-C), P14 (D-F), and P56 (G-I). Scale bar, 50 µm. 









 mice at P1 (n=6) , P14 (n=9) and P56 (n=10). Manf mRNA levels 




 compared to Manf
fl/fl
 islets. No 
difference in Manf mRNA expression levels was observed between Manf
fl/fl
 and Manf 
+/+
 islets 
confirming that the remaining Frt-site and LoxP sites in the introns flanking exon 3 in the Manf
fl/fl
 
gene does not disturb correct MANF pre-mRNA splicing and mRNA expression. Values represent 
mean ± SEM. *p < 0.05, **p < 0.01, ***p< 0.001. 
(K-N) Immunoperoxidase staining of MANF protein in P1 Pdx-1Cre+/-::Manffl/fl pancreas sections. 
MANF positive cells observed within the Langerhans islets (L, N), ducts and blood vessels (M) in 
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Supplementary Figure 3 
 
Supplementary Figure 3, supporting Figure 3. Positive correlation of Manf mRNA with 
mRNA levels of β-cell specific genes and ultrastructural morphology of islet β-cells in 4-week-
old Manf-/- pancreas.  
 (A-C) Positive correlation of Manf mRNA with Pdx-1 (A), Ins1/2 (B), Glut2 (C) mRNAs was 






  mice. n =9-10 mice per group. 
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(D-G) Representative electron microscopy images of islets from 4-week-old Manf+/+(D, E) and 
Manf
-/-
 (F, G) mice. Nucleus (N), endoplasmic reticulum(ER), secretory granule (SG), 
mitochondria (M). The loss of insulin secretory granules, enlarged mitochondria and dilated ER 
indicates ER stress-induced forthcoming β-cell demise in Manf
-/-
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Supplementary Figure 4 
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Supplementary Figure 4, supporting Figure 4. MANF induces proliferation of Manf
-/-
 β-cells 
and reduces ER stress caused by MANF-deficiency in β-cells. 
(A) Recombinant MANF protein at a concentration of 100 ng/ml increases proliferation of β-cells 
from 4-5-week-old Manf
-/-
 mice after 5 days in culture. n =quantified from 4-7 wells per group.  
 (B) Quantitative RT-PCR PCR analysis of UPR genes Atf4, Grp78, Chop, spXbp1, tXbp, Atf6a, 







treated with 1 µg/ml human recombinant MANF overnight in 0.5% BSA medium. Human 
recombinant MANF is able to reduce ER stress in Manf
-/-
 islets by downregulating UPR markers.  n 
= 3-4 per group.  
(C) Quantitative RT-PCR PCR analysis of UPR genes Atf4, Grp78, Chop, spXbp1, tXbp, Atf6a, 






 mice treated with 100 ng/ml human recombinant MANF for 3 days in 10% FBS medium. 
Human recombinant MANF is able to reduce expression levels of UPR markers Chop and spXbp1 
mRNA in isolated islets of Manf
-/-
 mice. Additionally, a small but insignificant increase was 
detected in Ins1/2 and Pdx1 mRNA expression in Manf
+/+
 islets treated with MANF for 3 days. n = 
3-4 per group. 
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Supplementary Figure 5.1 
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Supplementary Figure 5.1, supporting Figure 5. MANF-deletion in adult β-cells results in 





 (A) Serum insulin levels measured 4 weeks after tamoxifen or oil injection from ad libitum-fed 
mice, n = 2-13 mice per group.  
(B) Blood glucose levels measured after intraperitoneal glucose (2 g/kg) injection, n =2-12 mice per 
group. 
(C) Blood glucose levels measured after intraperitoneal insulin injection (1 U/kg), n = 4-6 mice per 
group.  
(D) Serum insulin levels measured from P90 mice 30 min after glucose bolus injection (2 g/kg), 
n =5-7 mice per group. 
(E) Relative Manf mRNA levels in islets isolated from Manf 
fl/fl
 mice injected with oil or tamoxifen 




 injected with oil or tamoxifen. n = islets from 7-9 mice per 
group. 
(F-W) Immunohistochemical analysis of MANF (F, I, L, O, R, U), insulin (G, J, M, P, S, V) and 
glucagon-positive (H, K, N ,Q ,T ,W) cells in pancreatic sections reveals morphological changes in 




injected with tamoxifen compared to control mice. Scale 
bar, 50 µm. 
(X) The β-cell mass is significantly reduced in P90 MIP-1CreERT::Manffl/fl mice injected with Tmx, 
compared to the β-cells mass in control mice, n = 2-6 mice per group. 
(Y) The islet-cell mass quantified from Chromogranin A antibody-stained sections is significantly 









mice injected with oil, n = 5-6 mice per group. 
(Z) α-cell mass in in P90 MIP-1CreERT::Manffl/fl mice injected with Tmx, compared to the α-cell 




mice injected with oil , n = 5-6 mice per group. 

























(OIL)  (A-E) and tamoxifen-injected MIP-1CreERT::Manffl/fl(TMX) (F-J). No 
noticeable changes were detected in MANF expression in the cortex (A, F), hippocampus (B, G), 
paraventricular nuclei of hypothalamus (PVN) (C, H), dorsal medial nuclei of hypothalamus 














Supplementary Figure 6 
 
Supplementary Figure 6, supporting Figure 7. Insights in the MANF mechanism of action 
 
(A-B) Relative Trib3 and Bcl10 mRNA levels in islets isolated from Manf+/+ and Manf-/- mice at 
postnatal day 1 (P1) and P14. n = islets from 3-5 mice per group. 
(C-G) Quantitative analysis of the western blot bands normalized to either total protein or GAPDH, 
1. Manf
+/+
 islets, 2. Manf
+/+
 islets cultured in the presence of 100 ng/ml of human recombinant 
MANF, 3. Manf
-/-
 islets, 4. Manf
-/-
 islets cultured in the presence of 100 ng/ml of human 
recombinant MANF. Mean ± SEM, *p < 0.05, ns., non-significant, of two independent experiments. 
n = 2-3.  














Dilution Country of 
origin 










1:500 Texas, USA 
Insulin ab7842, Abcam guinea pig 
polyclonal 
1:200 guinea pig 
polyclonal 
Insulin A0564, Dako guinea pig 
polyclonal 
1:2000 Santa Clara, 
California, US 
Glucagon ab10988, Abcam mouse 
monoclonal 
1:1000 Cambridge, UK 









1:1000 Texas, USA 
PP A0619, Dako rabbit 
polyclonal 
1:600 Santa Clara, 
California, US 
Somatostatin A0566, Dako rabbit  
polyclonal 








1:150 Waltham MA, 
USA 










1:200 San Jose, CA, 
USA 




1:500 Texas, USA 
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1:100 Texas, USA 
ERK1/2 K-23, sc-153 
Santa Cruz Biotechnology 
rabbit 
polyclonal 
1:500 Texas, USA 




















Dilution Country of 
origin 
















1:500 Texas, USA 
Chromogranin A ab15160, Abcam rabbit 
polyclonal 
 























Supplementary Table 2. Pearson´s correlation coefficient and Manders' coefficients for 






















      1 MANF 66 0.554 0.024 0.883 0.006 
ER 0.760 0.010 
      2 MANF 20 0.005 0.028 0.211 0.04 
Golgi 0.229 0.035 
      3 MANF 51 0.591 0.031 0.855 0.029 
Insulin 0.845 0.03 
      4 MANF 61 0.374 0.032 0.640 0.029 
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